KRAS

Mahmoud Yousef1, Abdelrahman Yousef1, Mark W Hurd2

  • 1Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

概括

液体活检 (LB) 在胰腺管腺癌 (PDAC) 中显示出显著的实用性,在超过80%的转移和50%的局部病例中检测出突变. 阳性LB,特别是KRAS突变,与转移性PDAC的生存率较差相关.

相关概念视频